clinical trial · NCT07287449
A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level
Dymicron·N/A·not yet recruiting·n = 164
Cervical Disc DiseaseTriadyme-C
brief summary
A multicenter, prospective, historically controlled study to evaluate the safety and effectiveness of the Triadyme-C device in comparison to other approved TDRs in the treatment of symptomatic cervical disc disease (SCDD) in subjects who are symptomatic at only a single level from C3 to C7 that are unresponsive to conservative management.
started
Jan 5, 2026
primary completion
Jul 31, 2029
completion
Jul 31, 2029
last updated
Dec 17, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol